Increased Doses of Adalimumab are Associated With Clinical Improvement of Hidradenitis Suppurativa

Journal article

Open access

Peer reviewed

Jazzmin C. Williams, Claudia Guzik, Akhil Wadhera and Haley B. Naik

Journal of drugs in dermatology, v 22(6), pp 615-617

01 Jun 2023

PMID: 37276155

Files and links (1)

url

https://doi.org/10.36849/JDD.6868View

Published, Version of Record (VoR) Open

1 Record Views

Title: Increased Doses of Adalimumab are Associated With Clinical Improvement of Hidradenitis Suppurativa
Creators: Jazzmin C. Williams - University of California, San Francisco
Claudia Guzik - College of Medicine, Drexel University, Philadelphia, PA, United States
Akhil Wadhera - Kaiser Permanente Fremont Medical Center
Haley B. Naik - University of California, San Francisco
Publication Details: Journal of drugs in dermatology, v 22(6), pp 615-617
Number of pages: 3
Resource Type: Journal article
Language: English
Academic Unit: Dermatology
Scopus ID: 2-s2.0-85160975668
Other Identifier: 991022207060404721